Anemia, ineffective erythropoiesis, and hepcidin: interacting factors in abnormal iron metabolism leading to iron overload in β-thalassemia.
about
Iron, hepcidin, and the metal connectionThe hepcidin-ferroportin system as a therapeutic target in anemias and iron overload disordersβ-thalassemia intermedia: a clinical perspectiveSuppression of hepcidin expression and iron overload mediate Salmonella susceptibility in ankyrin 1 ENU-induced mutantAn activin receptor IIA ligand trap promotes erythropoiesis resulting in a rapid induction of red blood cells and haemoglobinAltered erythropoiesis and iron metabolism in carriers of thalassemiaβ-thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism.Elevated liver iron concentration is a marker of increased morbidity in patients with β thalassemia intermediaErythrocyte Catalase Activity in More Frequent Microcytic Hypochromic Anemia: Beta-Thalassemia Trait and Iron Deficiency AnemiaReticulocyte hemoglobin equivalent to detect thalassemia and thalassemic hemoglobin variantsReducing TMPRSS6 ameliorates hemochromatosis and β-thalassemia in mice.Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patientsIron overload across the spectrum of non-transfusion-dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions.Curcumin may impair iron status when fed to mice for six months.Modulators of erythropoiesis: emerging therapies for hemoglobinopathies and disorders of red cell production.Iron overload correlates with serum liver fibrotic markers and liver dysfunction: Potential new methods to predict iron overload-related liver fibrosis in thalassemia patientsIron metabolism: interactions with normal and disordered erythropoiesisThe role of ineffective erythropoiesis in non-transfusion-dependent thalassemia.Anaemia in inflammatory rheumatic diseases.First Report of a Dominantly Inherited β-Thalassemia Caused by a Novel Elongated β-Globin Chain.Soluble hemojuvelin in transfused and untransfused thalassaemic subjects.GDF15-mediated upregulation of ferroportin plays a key role in the development of hyperferritinemia in children with hemophagocytic lymphohistiocytosis.High levels of soluble serum hemojuvelin in patients with congenital dyserythropoietic anemia type I.Gene Addition Strategies for β-Thalassemia and Sickle Cell Anemia.Endocrinopathies in transfusion-associated iron overload.What can we learn from ineffective erythropoiesis in thalassemia?Flow cytometric assessment of circulating platelet and erythrocytes microparticles in young thalassemia major patients: relation to pulmonary hypertension and aortic wall stiffness.Running exercise alleviates trabecular bone loss and osteopenia in hemizygous β-globin knockout thalassemic mice.Clinical presentation of the hemoglobin Youngstown variant in a Chinese family.Low hepcidin in liver fibrosis and cirrhosis; a tale of progressive disorder and a case for a new biochemical marker.
P2860
Q21129273-1CAD1090-5C8D-4AA4-96FB-9FAAA4D17E3BQ26823465-5073CAE0-CE73-4D47-B0BD-56A13E549B42Q26828512-577CB201-0281-4FC3-8295-C4D8391B578AQ28505375-424DA71B-208E-49DC-9A2E-BF3949616C62Q34803626-DEC467A1-0719-48A4-B6D4-7C021372A2D9Q35370845-424406E9-7134-4B69-932C-5D2A2B64266DQ35485724-6965A19A-9485-483A-A4EA-F518DEEFE0EFQ35528614-B97241C3-55A1-4D52-AFD4-693E9EC75EC7Q36191952-CAB78127-34C6-4B59-8F27-16F9351BD331Q36498732-DE68D676-4A64-42C2-8AE4-FFB0BD034879Q36733512-36830A6F-8E12-41D0-BFB0-966FDB626E5DQ36974108-4AA05186-522D-4363-9340-7661607082A0Q37595987-44AF1268-673D-4E6B-B374-7B8AAE280B46Q37636811-5D3E3202-755E-45CA-BC16-F651A2B6879AQ37673351-DA862ECD-A47A-4595-9B0A-09C0B61089C8Q37741820-F2692923-FDA4-4F32-A137-E7527CCFA8E7Q38007163-6BB084F1-520B-431B-975C-5090107B8E8CQ38013164-5F3719A7-D075-4EA3-A25E-1709A3A44B6AQ38059457-313CBA84-8E88-4842-BD55-7F04F7528A44Q40019124-1634AE82-8F72-40E9-98F4-16A4D7281439Q40605803-65DF1B71-6AD5-4424-8E68-FA1097083D9FQ44785565-4F48FC76-5DB8-40D3-8BBB-B25A097BBC4FQ45341194-C4968C28-3AEA-42ED-AFB0-F746295796B7Q45874313-56C8FF08-2761-4776-8328-87A1A810A390Q47391935-F472C197-7B2B-43DB-92ED-CE418D98FE99Q47885433-FAEF31BA-1A70-4B05-984D-496AD2C74D8DQ50493543-64D7A7F1-A95B-4747-B9D1-DEECF8BA5320Q51142755-99E141F4-4B97-482C-8CA1-48E69B49C11AQ51576442-B4A1E938-1F42-48A5-9B66-5EE1BE2955ACQ55438778-9F672962-5DC8-4127-A798-6B57DDF0267B
P2860
Anemia, ineffective erythropoiesis, and hepcidin: interacting factors in abnormal iron metabolism leading to iron overload in β-thalassemia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Anemia, ineffective erythropoi ...... ron overload in β-thalassemia.
@en
Anemia, ineffective erythropoi ...... ron overload in β-thalassemia.
@nl
type
label
Anemia, ineffective erythropoi ...... ron overload in β-thalassemia.
@en
Anemia, ineffective erythropoi ...... ron overload in β-thalassemia.
@nl
prefLabel
Anemia, ineffective erythropoi ...... ron overload in β-thalassemia.
@en
Anemia, ineffective erythropoi ...... ron overload in β-thalassemia.
@nl
P2860
P1476
Anemia, ineffective erythropoi ...... ron overload in β-thalassemia.
@en
P2093
Robert W Grady
Sara Gardenghi
P2860
P304
P356
10.1016/J.HOC.2010.08.003
P577
2010-10-15T00:00:00Z